The alarming number of children diagnosed with Autism Spectrum Disorders in recent years has increased significantly fro1 in 150 in 2000 to 1 in 68 by 2012 according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network.
Due to that increase, more and more parents have turned to alternative forms of treatments to counteract the underlying symptoms of autism. Traditional medicines have often failed at producing desired results for many patients with autism and their families. However, studies have demonstrated Hyperbaric Oxygen Therapy (HBOT) as an emerging treatment that parents and physicians are utilizing to help to improve cognitive, physical, mental and behavior functions of children in Autism Spectrum Disorders.
In 2009, a multi-center, randomized, controlled, double-blind trial was published in BMC Pediatrics, investigating the introduction of HBOT with 56 children diagnosed with ASD, ages 2-7. The study consisted of six separate HBOT centers that treated 30 children with 40 one hour sessions over the course of four weeks; whereas the remaining 26 children underwent sham treatment. Upon completion of this study, the treatment group experienced 80% improvement in overall functioning, receptive language, social interaction, and eye contact significantly. Major improvements were observed in irritability, stereotypy, hyperactivity, speech and sensory/cognitive awareness. Hyperbaric treatment was confirmed safe and well tolerated by the children and their parents in both groups.
These statements have not been evaluated by FDA. However, all of the statements are supported by clinical data, but individual response may vary.
The statements made on our websites have not been evaluated by the FDA (U.S. Food & Drug Administration). The information provided by this website is not a substitute for a face-to-face consultation with your physician, and should not be construed as individual medical advice. Our products are not intended to diagnose, cure or prevent any disease.